EUVIMEDEUVIMED entdecken
Crossref

In vitro antibacterial, antibiofilm, and antiadhesion efficacy of probiotics and their cell-free supernatants against hospital-acquired pathogens

Namphet Ubonsutvanich, Supontep Teerakanok, Rawee Teanpaisan, Nuntiya Pahumunto

Microbial Pathogenesis · 2026-09 · 218 · 108643

DOI: 10.1016/j.micpath.2026.108643 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Pathogenesis, 2026-09. Verfasst von Namphet Ubonsutvanich und 3 weiteren Autor:innen. Beteiligte Einrichtung: Periodontic Division, Department of Conservative Dentistry, Faculty of Dentistry, Prince of Songkla University, Hat Yai, Thailand. Hauptthemen laut MEDLINE: Probiotics, Biofilms, Bacterial Adhesion, Anti-Bacterial Agents. Die Arbeit nennt 49 Literaturangaben. Gefördert von: Prince of Songkla University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND The rise of hospital-acquired pathogens, probiotics and their cell-free supernatants (CFS) is being explored as alternative therapies. Thus, this study investigated antimicrobial activity, anti-biofilm, aggregation, and adhesion ability of the probiotics Lacticaseibacillus paracasei SD1(SD1), Lacticaseibacillus rhamnosus SD4(SD4), Lacticaseibacillus rhamnosus SD11(SD11), and Lactiplantibacillus plantarum SPS109(SPS109) and their CFS against hospital-acquired pathogens (Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa). METHODS Probiotics were grown in MRS broth and then centrifuged to separate cells from CFS. Live cells and their CFS were tested for antimicrobial activity. The CFS was used to determine the MIC and MBC assays. Probiotic antibiofilm and anti-adhesion, alongside CFS anti-adhesion activities, were determined via the plate count method, whereas CFS antibiofilm activity was assessed using the MTT assay. Aggregation was measured by spectrophotometry. Lacticaseibacillus rhamnosus GG(LGG) served as the positive control. RESULTS Probiotics (15.55±6.92 mm) exhibited higher antimicrobial activity than CFS (18.20±2.98 mm). Among probiotics, SPS109 demonstrated the strongest growth inhibition. MIC and MBC values of CFS showed 31.25-62.50 μg/ml and 62.50-250.00 μg/ml, respectively. Antibiofilm showed dose-dependent toxicity, with SPS109 (99.71-100.00%) and LGG (99.63-99.99%) exhibiting the most effective eradication. Among CFS, SD1 showed the highest eradication (36.08-96.39%). SD4 exhibited the highest auto-aggregation (81.61±4.78%), while SD1 exhibited high co-aggregation with pathogens (probiotics: 75.09±3.62%; CFS: 73.28±4.09%). SD1 and SD4 exhibited the highest anti-adhesion (0.18-33.64%) and anti-internalization (0.00-30.94%) of pathogens. CONCLUSION Probiotics and their CFS showed antagonistic effects against K. pneumoniae, P. aeruginosa, and A. baumannii. These findings could serve as an alternative method to treat infectious diseases caused by hospital-acquired pathogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsBiofilmsBacterial AdhesionAnti-Bacterial AgentsCross InfectionMicrobial Sensitivity TestsKlebsiella pneumoniaePseudomonas aeruginosaHumansAcinetobacter baumanniiLacticaseibacillus rhamnosusLactiplantibacillus plantarum

Stichwörter der Autor:innen

Aggregation abilityAnti-Adhesion abilityAntimicrobial activityCell-free supernatantsHospital-acquired pathogensProbiotics

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Periodontic Division, Department of Conservative Dentistry, Faculty of Dentistry, Prince of Songkla University, Hat Yai, Thailand.
  • Medical Science Research and Innovation Institute, Prince of Songkla University, Hat Yai, Thailand.
  • Research Center of Excellence for Oral Health, Faculty of Dentistry, Prince of Songkla University, Hat Yai, Thailand; Department of Oral Diagnostic Sciences, Faculty of Dentistry, Prince of Songkla University, Hat Yai,…

Förderung

  • Prince of Songkla University

Zitieren

APA

Ubonsutvanich, N., Teerakanok, S., Teanpaisan, R., & Pahumunto, N. (2026). In vitro antibacterial, antibiofilm, and antiadhesion efficacy of probiotics and their cell-free supernatants against hospital-acquired pathogens. Microbial Pathogenesis, 218, 108643. https://doi.org/10.1016/j.micpath.2026.108643

Vancouver

Ubonsutvanich N, Teerakanok S, Teanpaisan R, Pahumunto N. In vitro antibacterial, antibiofilm, and antiadhesion efficacy of probiotics and their cell-free supernatants against hospital-acquired pathogens. Microbial Pathogenesis. 2026;218:108643. doi:10.1016/j.micpath.2026.108643

BibTeX
@article{Ubonsutvanich2026,
  author = {Ubonsutvanich, Namphet and Teerakanok, Supontep and Teanpaisan, Rawee and Pahumunto, Nuntiya},
  title = {In vitro antibacterial, antibiofilm, and antiadhesion efficacy of probiotics and their cell-free supernatants against hospital-acquired pathogens},
  journal = {Microbial Pathogenesis},
  year = {2026},
  volume = {218},
  pages = {108643},
  doi = {10.1016/j.micpath.2026.108643}
}
Kostenlos starten →